Tampa Bay Business Journal covers Intelligence Ventures' national healthcare accelerator — a 10-week program investing $25K per startup, targeting 30 companies a year across AI healthcare, kicking off in Tampa this September with a demo day in NYC.
Read the article →One of Uruguay's leading news outlets profiles Intelligence Ventures and the "lead-user investor" model — how our LP Committee of biotech founders, surgeons, and pharma executives shapes every investment decision from the inside out.
The State of AI Healthcare Report went viral with 2,000 downloads in a week. We closed the four-city roadshow with 380 attendees, made two new portfolio investments (Directed Systems and MDC), launched an SPV in AGED Diagnostics, and Fund I closes May 25.
Read the update →After 2,000+ professionals signed up for our State of AI Healthcare report in two weeks, we took the findings live — featuring a deep dive into the 2026 report, portfolio startup pitches, and a panel with our Executive LP Committee.
Watch the recording →Intelligence Ventures integrates TurboInnovate's innovation intelligence platform into its deal workflow — replacing six-figure consulting engagements with validated competitive landscapes, IP analysis, and funding trajectories in minutes.
Read the press release →Doug shares what investors look for in pre-seed and seed-stage biotech startups, how AI is transforming drug development and MedTech, and lessons from advising 25+ life sciences and tech companies.
Watch the interview →Doug Nissinoff joins the Emerging Managers Podcast to discuss AI and healthcare venture investing, Intelligence Ventures' thesis, and lessons from building a fund.
Listen to the episode →The February 2026 newsletter from the desk of Doug Nissinoff, Founder & General Partner, with updates on the fund, portfolio, and the AI healthcare landscape.
Read the newsletter →